• Log in with Facebook Log in with Twitter Log In with Google      Sign In    
  • Create Account
  LongeCity
              Advocacy & Research for Unlimited Lifespans

Photo
* * * * - 16 votes

Nicotinamide Riboside [Curated]

nicotinamide riboside nicotinamide nad boosting charles brenner david sinclair leonard guarente niagen niacinamide nicotinamide mononucleotide

  • This topic is locked This topic is locked
2255 replies to this topic

#211 Castiel

  • Guest
  • 384 posts
  • 89
  • Location:USA

Posted 15 February 2016 - 11:44 PM

 

 

 

 

 

 

Im not sure to agree with that and resveratrol I think was shown to activate sirt1 in an independent manner. Im not sure more NAD+ wil influence it.

 

However, a point interesting enough is that sirt1 block parp1. Bryan can you confirm this ?

 

Im trying to connecting the dots, and would like to make a pics the more complete as we can where we show the main pathways

 

EDIT: about sirt1 activity while we age: http://journals.plos...ne.0042357.t001 as you can see there is no strong difference and we can even say no statistical difference. Female do not have decrease in sirt1..

 

However, its even more clear that the main problem remain the loss of NAD+ due to PARP1 activity. Again and again, this is the main problem: DNA damage.

 

 

Resveratrol increases sirt1 activity indirectly, that doesn't mean sirt1 can function adequately(benefit from substances that increase it activity to levels were it might positively affect lifespan) with suboptimal NAD+.

 

From that linked graph, if I'm reading it correctly, it seems sirt1 activity drops from around 30 to 11, though it seems the level of variability also increases with age.  Which would suggest some appear to retain more youthful levels of sirt1 activity.  But again regards elderly, some drop dead at 80, while others live to 100 or more, so it is to be expected that if sirt1 contributed to increased lifespan there might be increased variability in the elderly population given the variability in remaining lifespan.


Edited by Castiel, 15 February 2016 - 11:50 PM.


#212 Tom Andre F. (ex shinobi)

  • Guest
  • 423 posts
  • 111
  • Location:France

Posted 16 February 2016 - 12:05 PM

Castiel,

 

yes this is true regarding suboptimal NAD+ level. But age-induced reduction in SIRT1 activity can also be due to increasing levels of Nicotinamide (from diet), and increasing levels of DBC1.

 

As you can read in the full study which i think is the most reliable however, even if conflicting result on mice exist, is that the sirt1 activity on female is not a matter while they still age.. and sirt1 remain statistically stimilar for new born, younf adult and adult while only a group of male elerdy have a real decrease as you mentioned. The real marker you have to consider are dna damade (though ph2aX), PARP over expression with aging and NAD+ depletion. All linked: If we fix DNA damage we probably fix PARP, and then NAD+..

 

We should focus on:

 

-does sirt1 really block parp1 in healthy cells ? if so by which mechanism ?

- is supplementing with NR will break down into nicotinamide metabolites into the blood AND within the cells (causing on the long run a very bad health effect, knowing the role of sirt1): I want to know if accumulation can be increased here because this case is already maybe done via normal niacin diet). Im sure its possible to have this info. Actually we must have, because here we advice to supplement always more and often with NR without considering that point. I point again the fact we will have to make a strict difference between blood plasma nicotinamide AND accumulation within the cells wich is far more complicated to proof. Then only I would feel safeto consume NR but still have to fix the loop and the DNA damage (maybe the theory of massive inflammation is legit)


  • Agree x 1

#213 Logic

  • Guest
  • 2,666 posts
  • 593
  • Location:Kimberley, South Africa
  • NO

Posted 16 February 2016 - 04:31 PM

Castiel,

 

yes this is true regarding suboptimal NAD+ level. But age-induced reduction in SIRT1 activity can also be due to increasing levels of Nicotinamide (from diet), and increasing levels of DBC1.

 

As you can read in the full study which i think is the most reliable however, even if conflicting result on mice exist, is that the sirt1 activity on female is not a matter while they still age.. and sirt1 remain statistically stimilar for new born, younf adult and adult while only a group of male elerdy have a real decrease as you mentioned. The real marker you have to consider are dna damade (though ph2aX), PARP over expression with aging and NAD+ depletion. All linked: If we fix DNA damage we probably fix PARP, and then NAD+..

 

We should focus on:

 

-does sirt1 really block parp1 in healthy cells ? if so by which mechanism ?

- is supplementing with NR will break down into nicotinamide metabolites into the blood AND within the cells (causing on the long run a very bad health effect, knowing the role of sirt1): I want to know if accumulation can be increased here because this case is already maybe done via normal niacin diet). Im sure its possible to have this info. Actually we must have, because here we advice to supplement always more and often with NR without considering that point. I point again the fact we will have to make a strict difference between blood plasma nicotinamide AND accumulation within the cells wich is far more complicated to proof. Then only I would feel safeto consume NR but still have to fix the loop and the DNA damage (maybe the theory of massive inflammation is legit)

 

I cant post links or smilies atm but

SIRT1 Promotes Cell Survival under Stress by Deacetylation-Dependent Deactivation of Poly(ADP-Ribose) Polymerase 1

PMC2715814

 

Will help as it explains nicely how SIRT controls  PARP by deacetylation  and tells you what, besides DNA damage (over?) activates PARP:

  • phosphorylation,
  • high levels of Mg2+, Ca2+
  • polyamines
  • PCAF. Also known as K(lysine) acetyltransferase 2B (KAT2B)

See

Bromodomains as therapeutic targets 

PMC3177561

for a link to inflammation.
 


Edited by Logic, 16 February 2016 - 04:32 PM.


#214 Castiel

  • Guest
  • 384 posts
  • 89
  • Location:USA

Posted 16 February 2016 - 04:55 PM

Can't link to the other graph in the paper(forum restrictions), but there's a graph for the sirt1 changes in females and males in that paper.

Well looking at the graph there is one outlier in this graph, that might skew it, as it seems there are only like 3 people in the last female age group.  There are also quite few, involved.  Also I'm going off of the numbers in the table you linked, going by it there is a decrease, and it might not show given the outlier in the graph with only 3 people.

 

Regards rodents here's the relevant quote from that same article(relevant as it may elucidate resveratrol's failure in normal rodents to increase lifespan)

 

However, it should be remembered that SIRT1 activity is dependent on adequate NAD+ availability. Recently, our laboratory reported a significant decline in SIRT1 activity consistent with a decline in NAD+ levels in the heart, lung, liver and kidney in an aging rat model [36]. This was consistent with the hypothesis that NAD+ levels impact on SIRT1 activity
plos 0042357


 

Consistent with this prediction we report for the first time a significant decline in SIRT1 activity with age in post pubescent males (Fig. 5A, line b), though surprisingly, not in females (Fig. 5B)

I think too few individuals were used at the greater ages, and the outlier affected the results.  Also  I should note, that normal levels of sirt1 activity need not be indicative of how NAD+ might limit enhanced or increased activity through substances such as resveratrol.   While, it might or might not affect normal levels of activity it may or may not impede increased activity from being facilitated.
 

 

All linked: If we fix DNA damage we probably fix PARP, and then NAD+..
 

IIRC, I think the reason DNA damage is likely increasing is likely due to altered gene expression that downregulates protein turn over and probably dna repair.   I think Michael Fossel suggested restoring telomeres to more youthful levels reverses the gene expression and protein turn over age related adverse effects, restoring cells to more youthful states, or something like that in his latest book.

 

EDIT

 

Several studies point out age-related decrease in expression of DNA repair enzymes or their activities...Why do levels of DNA repair enzymes decline with age, and why are all the DNA repair systems affected?...- paper

Changes in DNA repair during aging

 


Edited by Castiel, 16 February 2016 - 05:12 PM.


#215 LucidMind

  • Guest
  • 49 posts
  • 12
  • Location:San Francisco, CA
  • NO

Posted 16 February 2016 - 09:37 PM

My research has me conflicted on the role of nicotinamide riboside in treating or preventing cancer. New cancer therapies are exploring the inhibition of NAMPT(

nicotinamide phosphoribosyltransferase). 

 

See:

 

Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) as a therapeutic strategy in cancer

 

Supplementation of nicotinic acid with NAMPT inhibitors results in loss of in vivo efficacy in NAPRT1-deficient tumor models

 

Dependence of tumor cell lines and patient-derived tumors on the NAD salvage pathway renders them sensitive to NAMPT inhibition with GNE-618

 

Loss of NAPRT1 expression by tumor-specific promoter methylation provides a novel predictive biomarker for NAMPT inhibitors

 

It seems that increasing NAD+ may help tumor cells proliferate and strategies to inhibit the formation of NAD+ may serve to shrink tumor cells.

 

On the other hand you have the study that came out that showed increasing levels of NAD+ in liver cancer reversed the disease in those mice that had it as well as prevented in the mice. 

 

See:

 

Inhibition of de novo NAD(+) synthesis by oncogenic URI causes liver tumorigenesis through DNA damage

 

It seems one conclusion is that nicotinamide riboside could be harmful or helpful depending on the type of tumor. Anyone have thought on this?



#216 Bryan_S

  • Topic Starter
  • Guest
  • 1,217 posts
  • 410
  • Location:Orlando

Posted 17 February 2016 - 03:37 AM

Im not sure to agree with that and resveratrol I think was shown to activate sirt1 in an independent manner. I'm not sure more NAD+ will influence it.

 

SIRT 1 is NAD+ dependent, just raising SIRT levels will not increase their activity unless there is sufficient NAD+ to perform the work.

This was one of the key contributions of David Sinclair, Leonard Guarente and Shin-ichiro Imai because raising Sirtuin levels failed to produce results unless there was sufficient NAD+ to power the reaction. See How Sirtuin Deacetylation Impacts Genetic Expression Also see Resveratrol, Niacin, Nicotinamide Riboside: Key Players in Activating Sirtuins to Mimic Calorie Restriction & Extend Lifespan, Part II It's a pretty good explanation of the interrelated dependencies of all these enzymes. Lara Pizzorno is a member of the American Medical Writers Association and easily boils down these relationships. 

 

 

My research has me conflicted on the role of nicotinamide riboside in treating or preventing cancer. New cancer therapies are exploring the inhibition of NAMPT(

nicotinamide phosphoribosyltransferase). 

 

LucidMind, It's a drawn out story, nicotinamide can be an inhibitor of some of the cellular repair processes but nicotinamide riboside is not. Its funny that David Sinclair's study was one to say Nam downregulates SIRT1 and other NAD dependent enzymes, he's also came around 180 degrees and defended Niacinamide, have you read that? This sounds odd but he makes a good point. "One must be careful when calling nicotinamide an "inhibitor" in this experiment. While it is true that our lab showed that nicotinamide is a direct inhibitor of SIRT1 enzyme, it is also a precursor of NAD+, and NAD+ is a co-substrate (i.e., activator) of SIRT1.

 

In vivo, there is an abundant enzyme called Nampt in cells and serum that initiates the conversion of nicotinamide to NAD+. Therefore we should entertain the possibility that nicotinamide is activating SIRT1 in vivo, not inhibiting it. This would fit with other papers showing that SIRT1 is neuroprotective." He defines in vitro and in vivo, in a test tube and in a living organism. PARP is also inhibited like SIRT1 with nicotinamide but when the balance changes with increasing NAD+ thru NAMPT enzyme activity resumes. 

 

It can be confusing however let's not cross our wires when discussing healthy vs. cancer tissues. On the prevention side, where most of us stand, we still need to power/enable our DNA error correction, PARP ect. and these enzymes are all NAD+ dependent. Keep in mind we experience "DNA damage, due to environmental factors and normal metabolic processes inside the cell, occurs at a rate of 10,000 to 1,000,000 molecular lesions per cell per day." See Types of damage.

 

Wilson cloud chamber cosmic radiation tracks - indoors at sea level. This video depicts the background radiation we all receive on a moment to moment basis. "The atmosphere shields us from cosmic rays about as effectively as a 13-foot layer of concrete, yet a large proportion of cosmic ray particles manages to send fragments all the way through it." This is the environment our biology evolved to cope with. 

 

On the other hand as energy is produced within the mitochondria, in the form of ATP, free radicals are emitted—the same free radicals that are a common byproduct of radiation as mentioned above. In essence, the power produced by the mitochondria comes with a certain amount of cellular destruction. This is why the cell has moved critical DNA out of the mitochondria and into the nucleus for better protection.

 

I've had this discussion with others before, when we are young we are well equipped to deal with the daily damage and all of our repair mechanisms are set to maximum. There are rare cases where cancer can develop in our youth do to other factors but statistically these numbers are rather low in comparison to the average population/age and when cancers become a higher risk. We've evolved as a species in an environment where we receive external radiation and internal chemical factors that both produce cellular damage. (we were built with the ability/tools to perform the necessary maintenance) So if we turn off our NAD pathways we also starve our repair mechanisms but there are times when this may be appropriate and warranted under a doctor's care.

 

In the Cancer therapy arena they have found that attacking NAD pathways can be a target to stress and help kill "some" cancers and this type of approach may involve other chemotherapies as the final death blow to wipe out that mutant cell. This study came to mind but there are many others.

 

Now I'm not an Oncologist but this approach is a way to weaken the NAD energy pathways Cancer needs to survive, so this can be a beneficial treatment approach as suggested. Keep in mind it also affects healthy tissue as well, reducing the ability of those cells to perform DNA maintenance thru the NAD dependent PARP enzymes.

 

It's not unheard of to hear about unrelated "separate" cancers developing after weakening the cells DNA maintenance and repair with these chemo's. "Chemotherapy Can Inadvertently Encourage Cancer Growth" So the primary cancer can get help from the surrounding tissue and secondary cancers can develop within the healthy tissues as collateral damage. Within this strategy PARP inhibitors may also be employed by keeping cancer cells from repairing themselves once they've been damaged by chemotherapy. So this is why several approaches are often used together to block the recovery of the targeted cells. If you are a cancer patient I would openly discuss NAD boosting with your Oncologist because they can let you know when and when not to use the NAD precursors and there might be an appropriate time to resume them after the chemo treatment.

 

So for most of us we want our cells to keep vigilant in repairing our daily NAD lesions and this ability slowly drops with age and our NAD levels. This one reason out of many why we follow NAD boosting. But if we are in the situation of being under the care of an Oncologist and they are trying to cripple or slow-down a cancer making it more susceptible to another chemotherapy or radiation I would follow their instructions to the letter to ensure success but I would still ask a lot of questions regarding the known risks to my healthy tissue.

 

Hope that helps.

 

For those walking this path my heart goes out to you but this should be a discussion with your Doctor. My opinions should really only be used to stimulate these questions. One area many of us have begun to look into for cancer prevention and as a supplement to chemo is honokiol. This is why I believe honokiol could be the Swiss Army knife in cancer treatment. Not an inticment/recommendation as a cure but the research is well worth reading.

 

Sorry I didn't see the start of these questions but I'm on the road and away from my keyboard.


Edited by Bryan_S, 22 February 2016 - 02:59 AM.
background radiation and mitochondrial energy damage update, How Sirtuin Deacetylation Impacts Genetic Expression, David Sinclair defends nicotinamide

  • Informative x 1

#217 Logic

  • Guest
  • 2,666 posts
  • 593
  • Location:Kimberley, South Africa
  • NO

Posted 17 February 2016 - 08:12 AM

"SIRT 1 is NAD dependent, just raising SIRT levels will not increase their activity unless there is sufficient NAD to perform the work."

Agreed, except you mean 'trying to raise SIRT'

 

NAD+ will raise levels of everything dependant in it.

ie: SIRT, PARP, CD38 etc.

(Upregulating NAMPT is the best way of doing this IMHO as it will keep intracellular NAM levels down and NAM downregulates SIRT, PARP etc.)

Then SIRT1 will control PARP levels by de-acetylation of PARP activated by things other than DNA breaks. 

See my previous post.
As there are things, besides DNA damage,  that raise PARP to dangerous levels; increasing SIRT with R and/or Pt is a very important consideration IMHO! 

See my previous post and google the study title/s you lazy buggers! :)

 

Now in vivo Pt is likely to give the results seen in vitro with R due to a much longer half life and much better bioavailability IMHO.

Ask yourself: WTF did Sinclair et-al added Pt to their NR tablets.........!?

 

The in vitro/vivo research results have been the source of much confusion and argument here.
Keeping the difference in mind and reading about PT and  R and their metabolites cleared that up for me.  Try it!   :)

Here are blog post/s by myself and Tom on Pt:

http://www.pterostilbene.com/

WTF happened to the bioavailability post Tom?

 


Edited by Logic, 17 February 2016 - 08:22 AM.


#218 midas

  • Guest
  • 417 posts
  • 82
  • Location:Manchester....UK
  • NO

Posted 17 February 2016 - 03:21 PM

Just a thought, but if certain cancers thived on NAD, wouldn't they be more prevalent in our youth when we have higher levels of NAD?


Edited by midas, 17 February 2016 - 03:48 PM.

  • Good Point x 1

#219 bluemoon

  • Guest
  • 762 posts
  • 94
  • Location:south side
  • NO

Posted 17 February 2016 - 05:24 PM

Just a thought, but if certain cancers thived on NAD, wouldn't they be more prevalent in our youth when we have higher levels of NAD?

 

Not if other factors of youthful cells overcame that.


  • Agree x 1

#220 midas

  • Guest
  • 417 posts
  • 82
  • Location:Manchester....UK
  • NO

Posted 18 February 2016 - 12:59 AM

 

Just a thought, but if certain cancers thived on NAD, wouldn't they be more prevalent in our youth when we have higher levels of NAD?

 

Not if other factors of youthful cells overcame that.

 

 

But NAD is in all cells, and we're lead to believe in larger amounts when we are younger...


  • Ill informed x 1

#221 Logic

  • Guest
  • 2,666 posts
  • 593
  • Location:Kimberley, South Africa
  • NO

Posted 18 February 2016 - 05:52 AM

 

 

Just a thought, but if certain cancers thived on NAD, wouldn't they be more prevalent in our youth when we have higher levels of NAD?

 

Not if other factors of youthful cells overcame that.

 

 

But NAD is in all cells, and we're lead to believe in larger amounts when we are younger...

 

 

IMHO:

  • You don't have the buildup of:AGEs, lipofuscin, etc.
  • You arent full of low level chronic infections. (Ever notice the link between viral infection and cancer?  Think HPV vaccine and Cervical cancer and then see how many cancers you can find that aren't somehow linked to a virus.  They change your DNA to do what they want...)
  • Your telomeres are long and very little DNA damage has occurred. http://www.longecity...ndpost&p=716857
  • Your gut isn't leaking toxins and pathogens into the rest of you.

ie: Conditions are optimal for the use of optimal epigenetics, so the body does not have to compromise to avoid cancer.  Hence the high NAD+ levels.  IMHO.

 

Slaying Two Dragons with One Stone – How to Prevent Cancer and Aging with the Same Strategy

http://www.anti-agin... with One Stone

 

Warburg Effect search:

http://www.anti-agin...=warburg effect

 

Once you understand the warburg effect and how to 'turn on' 'switched off' mitochondria; you won't be nearly as worried about cancer.  Well I'm not.  :)


Edited by Logic, 18 February 2016 - 06:05 AM.


#222 bluemoon

  • Guest
  • 762 posts
  • 94
  • Location:south side
  • NO

Posted 18 February 2016 - 10:32 AM

I just read this from "Slice of MIT",  Jan 15, 2016

https://slice.mit.ed...m-mit-research/

 

"Basis [NR and  pterostilbene] was first released for sales in February 2015 after initial human trials, additional trials for safety and efficacy began in January 2016. Run by an independent group, these trials will result in a report, slated to be published in late 2016, that is expected to expand the safety data and begin to test efficacy in humans."

 

"The trials, placebo-controlled and double-blind, will measure markers of good health like blood glucose, lipids, levels of inflammation, sleep and energy, as well as tests based on physical capacity."

---

 

If I'm reading this correctly, then the efficacy results have been pushed back about a half a year to a year.


Edited by Bryan_S, 19 February 2016 - 02:06 AM.


#223 Tom Andre F. (ex shinobi)

  • Guest
  • 423 posts
  • 111
  • Location:France

Posted 18 February 2016 - 11:18 AM

"SIRT 1 is NAD dependent, just raising SIRT levels will not increase their activity unless there is sufficient NAD to perform the work."

Agreed, except you mean 'trying to raise SIRT'

 

NAD+ will raise levels of everything dependant in it.

ie: SIRT, PARP, CD38 etc.

(Upregulating NAMPT is the best way of doing this IMHO as it will keep intracellular NAM levels down and NAM downregulates SIRT, PARP etc.)

Then SIRT1 will control PARP levels by de-acetylation of PARP activated by things other than DNA breaks. 

See my previous post.
As there are things, besides DNA damage,  that raise PARP to dangerous levels; increasing SIRT with R and/or Pt is a very important consideration IMHO! 

See my previous post and google the study title/s you lazy buggers! :)

 

Now in vivo Pt is likely to give the results seen in vitro with R due to a much longer half life and much better bioavailability IMHO.

Ask yourself: WTF did Sinclair et-al added Pt to their NR tablets.........!?

 

The in vitro/vivo research results have been the source of much confusion and argument here.
Keeping the difference in mind and reading about PT and  R and their metabolites cleared that up for me.  Try it!   :)

Here are blog post/s by myself and Tom on Pt:

http://www.pterostilbene.com/

WTF happened to the bioavailability post Tom?

Very interesting point about NAMPT. Will look deeper into this.

 

For pterostilbene im also sure its also much better than resveratrol since its more oil soluble, so will enter better into the cells.

 

For the page, do you mean this one: http://www.pterostil...armacokinetics/ ?


 



#224 bluemoon

  • Guest
  • 762 posts
  • 94
  • Location:south side
  • NO

Posted 18 February 2016 - 05:56 PM

 

Now in vivo Pt is likely to give the results seen in vitro with R due to a much longer half life and much better bioavailability IMHO.

Ask yourself: WTF did Sinclair et-al added Pt to their NR tablets.........!?

 

Very interesting point about NAMPT. Will look deeper into this.

 

For pterostilbene im also sure its also much better than resveratrol since its more oil soluble, so will enter better into the cells.

 

For the page, do you mean this one: http://www.pterostil...armacokinetics/ ?

 

 

Is Sinclair even connected to Elysium which adds pterostilbene to NR?

 

Note that Sinclair said a few months ago in a WaPo interview that he takes 1000 mg of resveratrol a day yet also said in a Q&A in late 2014 that while he takes resveratrol, he thought it was "old technology and that there is better, the NAD route." [paraphrase]

 

The plot thickens as Guarente said in an interview that he takes NR/pterostilbene [Elysium] but in another interview said that he also 250 mg of resveratrol a day. I wonder why both resveratrol and pterostilbene.  

 

I'm sure we will know more soon... by 2021.



#225 Logic

  • Guest
  • 2,666 posts
  • 593
  • Location:Kimberley, South Africa
  • NO

Posted 18 February 2016 - 09:07 PM

Ah thx Tom.  Yes:

http://www.pterostil...armacokinetics/ ?

 

My pterostilbene folder/notes. Untouched, except for permission settings:

https://docs.google....dit?usp=sharing
 

Piceatannol is the twist in the tale

:)

 


Edited by Logic, 18 February 2016 - 09:09 PM.


#226 Bryan_S

  • Topic Starter
  • Guest
  • 1,217 posts
  • 410
  • Location:Orlando

Posted 19 February 2016 - 02:38 AM

NAD+ will raise levels of everything dependant in it.

ie: SIRT, PARP, CD38 etc.

(Upregulating NAMPT is the best way of doing this IMHO as it will keep intracellular NAM levels down and NAM downregulates SIRT, PARP etc.)

 

 

Novel class of NAMPT activators for neurodegenerative disease discovered

https://www.scienced...40911135320.htm

 

NAMPT as a Therapeutic Target against Stroke

http://www.cell.com/...6147(15)00182-0

 

Dietary proanthocyanidins modulate BMAL1 acetylation, Nampt expression and NAD levels in rat liver

http://www.nature.co...icles/srep10954

 

P7C3

http://www.selleckch...ducts/p7c3.html

 

 

I don't think there is a market in these agents and it is not yet known if the use of such activators will help in the retention of B3. 


  • Informative x 1

#227 albedo

  • Guest
  • 2,119 posts
  • 756
  • Location:Europe
  • NO

Posted 19 February 2016 - 04:07 PM

I found the following interesting (bold is mine) in relation to the NR protective role and the PARP inhibition, in particular for prostate cancer.

 

Nicotinamide Riboside Delivery Generates NAD+ Reserves to Protect Vascular Cells Against Oxidative Damage

 “…This study determines if nicotinamide riboside (NR) delivery can augment NAD+ stores and fuel resistance to oxidative stress. I established that oxidative-stress insult on vascular cells decreased NAD+ levels, accompanied by a striking increase in nuclear PAR-chain accumulation. PARP inhibition abolished PAR-chain formation and preserved NAD+ levels, establishing PARP in NAD+ consumption in this model. NR delivery protected against cell-shrinkage and cell death and promoted DNA repair efficiency. PARP inhibition mimicked NR’s beneficial effects on cell-shrinkage and viability but at the cost of DNA repair efficiency…”

http://ir.lib.uwo.ca/etd/2891/

 

In another article titled “Scientists unveil prostate cancer’s ‘Rosetta Stone’”, “ … Researchers analysed the genetic codes of metastatic tumors from the bone, soft tissues, lymph nodes and liver of 150 patients with advanced prostate cancer. Nearly two thirds of the men in the study had mutations in a molecule that interacts with the male hormone androgen which is targeted by current standard treatments – potentially opening up new avenues for hormone therapy.  Mutations in the BRCA1 and BRCA2 genes – most famous for their roles in breast cancer – were found in nearly 20% of patients. Recent work at the ICR and The Royal Marsden has shown that these patients can be treated effectively by drugs called PARP inhibitors. Researchers also discovered new mutations, never detected before in prostate cancer, but which do occur in other cancers. These include mutations in the PI3K and RAF gene families which can also be targeted by existing drugs, either currently in trials or approved for use in the clinic…”

http://www.icr.ac.uk/news-archive/scientists-unveil-prostate-cancer-s-rosetta-stone

 

 

 



#228 Ethic

  • Guest
  • 52 posts
  • 12
  • Location:Vienna

Posted 22 February 2016 - 02:20 PM

Grape seed extract modulates NAMPT expression in rat liver

 

http://www.nature.co...icles/srep10954

 

 

NAMPT is over-expressed in some cancer types

 

http://www.nature.co...nc2010468a.html

 

 

NAMPT inhibition is a possible cancer therapy

 

http://www.nature.co...is2014564a.html

 

 


  • like x 1

#229 Bryan_S

  • Topic Starter
  • Guest
  • 1,217 posts
  • 410
  • Location:Orlando

Posted 22 February 2016 - 05:59 PM

ChromaDex Announces Commencement of an Obesity-Related Clinical Study of NIAGEN® in Collaboration With the University of Copenhagen and Aarhus University
Dr. Jonas Treebak, a Researcher With The Novo Nordisk Foundation Center for Basic Metabolic Research (University of Copenhagen, Denmark) Will, in Collaboration With Researchers at Aarhus University, Investigate the Metabolic and Insulin Sensitizing Effects of NIAGEN® in Obese Healthy Adults Aged 40-70 Years

 

http://investors.chr...icle&ID=2141473



#230 Bryan_S

  • Topic Starter
  • Guest
  • 1,217 posts
  • 410
  • Location:Orlando

Posted 22 February 2016 - 06:38 PM

Grape seed extract modulates NAMPT expression in rat liver

 

http://www.nature.co...icles/srep10954

 

Thanks for the Grape seed info on modulating NAMPT. "In conclusion, PAs modulate the molecular clock in the liver even though their effectiveness depends largely on the time of administration." As we look for activators of NAMPT to heighten NAD+ this one appears to signal to modulate the molecular clock in the liver. So overall the timing of its ingestion can heighten the production of NAMPT but not so much when taken during off hours.

 

Did I read this right, it had its greatest effect when administered at the beginning of the active wake cycle. Which for the rats was at dusk. Can we pin this down to a human 24-hour circadian cycle? I assume this equates to when we wake up?

 

Some of us already take this for blood pressure and I take it in my AM stack and again in my PM stack before bed. Sounds like some of us can optimize our efforts by choosing the correct time of day for its administration boosting NAD+.

 

Nice find Ethic!



#231 bluemoon

  • Guest
  • 762 posts
  • 94
  • Location:south side
  • NO

Posted 22 February 2016 - 09:51 PM

 

ChromaDex Announces Commencement of an Obesity-Related Clinical Study of NIAGEN® in Collaboration With the University of Copenhagen and Aarhus University
Dr. Jonas Treebak, a Researcher With The Novo Nordisk Foundation Center for Basic Metabolic Research (University of Copenhagen, Denmark) Will, in Collaboration With Researchers at Aarhus University, Investigate the Metabolic and Insulin Sensitizing Effects of NIAGEN® in Obese Healthy Adults Aged 40-70 Years

 

http://investors.chr...icle&ID=2141473

 

 

So a new study is underway at the U of Copenhagen but the results of last year's NR study are still not known, right? 



#232 to age or not to age

  • Guest
  • 151 posts
  • 93
  • Location:NY

Posted 22 February 2016 - 10:16 PM

 

 

Now in vivo Pt is likely to give the results seen in vitro with R due to a much longer half life and much better bioavailability IMHO.

Ask yourself: WTF did Sinclair et-al added Pt to their NR tablets.........!?

 

Very interesting point about NAMPT. Will look deeper into this.

 

For pterostilbene im also sure its also much better than resveratrol since its more oil soluble, so will enter better into the cells.

 

For the page, do you mean this one: http://www.pterostil...armacokinetics/ ?

 

 

Is Sinclair even connected to Elysium which adds pterostilbene to NR?

 

Note that Sinclair said a few months ago in a WaPo interview that he takes 1000 mg of resveratrol a day yet also said in a Q&A in late 2014 that while he takes resveratrol, he thought it was "old technology and that there is better, the NAD route." [paraphrase]

 

The plot thickens as Guarente said in an interview that he takes NR/pterostilbene [Elysium] but in another interview said that he also 250 mg of resveratrol a day. I wonder why both resveratrol and pterostilbene.  

 

I'm sure we will know more soon... by 2021.

 

Here are my two cents:  I have known Lenny Guarante for almost 10 years, I know David somewhat, having interviewed him and gone back and forth over some years. David is not involved in Elysium that I know of, although Lenny's group did use Sitris's insights for delivery of Basis into the body. So maybe 

there was some financial recompense.  Last July (ish) David emailed me and asked in response to something I had brought up about beta lapachone:

' Beta Lapachone is very interesting. Do you have a trusted source for beta lapachone; do you take it?' That is close to a quote. Another aging researcher

I know had also zeroed in on the NAD rationed beta lapachone. Bottom line here is that I think they think beta lapachone could be the missing link.  I actually didn't tell Lenny or David, but I have been having beta lapachone synthesized since September, a small amount has been rendered, they will finish building top material by early April, test it etc - my intention is to try it in different combinations (resveratrol, rapamycin etc) on mice. I may give David and Lenny some.  It will be independently tested again after the chemists turn it over to me.  Robert Kane Pappas

because they have been generous sources for my film research.   


  • like x 3
  • Informative x 2
  • Agree x 1

#233 to age or not to age

  • Guest
  • 151 posts
  • 93
  • Location:NY

Posted 23 February 2016 - 01:07 AM

 

 

 

Now in vivo Pt is likely to give the results seen in vitro with R due to a much longer half life and much better bioavailability IMHO.

Ask yourself: WTF did Sinclair et-al added Pt to their NR tablets.........!?

 

Very interesting point about NAMPT. Will look deeper into this.

 

For pterostilbene im also sure its also much better than resveratrol since its more oil soluble, so will enter better into the cells.

 

For the page, do you mean this one: http://www.pterostil...armacokinetics/ ?

 

 

Is Sinclair even connected to Elysium which adds pterostilbene to NR?

 

Note that Sinclair said a few months ago in a WaPo interview that he takes 1000 mg of resveratrol a day yet also said in a Q&A in late 2014 that while he takes resveratrol, he thought it was "old technology and that there is better, the NAD route." [paraphrase]

 

The plot thickens as Guarente said in an interview that he takes NR/pterostilbene [Elysium] but in another interview said that he also 250 mg of resveratrol a day. I wonder why both resveratrol and pterostilbene.  

 

I'm sure we will know more soon... by 2021.

 

Here are my two cents:  I have known Lenny Guarante for almost 10 years, I know David somewhat, having interviewed him and gone back and forth over some years. David is not involved in Elysium that I know of, although Lenny's group did use Sitris's insights for delivery of Basis into the body. So maybe 

there was some financial recompense.  Last July (ish) David emailed me and asked in response to something I had brought up about beta lapachone:

' Beta Lapachone is very interesting. Do you have a trusted source for beta lapachone; do you take it?' That is close to a quote. Another aging researcher

I know had also zeroed in on the NAD rationed beta lapachone. Bottom line here is that I think they think beta lapachone could be the missing link.  I actually didn't tell Lenny or David, but I have been having beta lapachone synthesized since September, a small amount has been rendered, they will finish building top material by early April, test it etc - my intention is to try it in different combinations (resveratrol, rapamycin etc) on mice. I may give David and Lenny some.  It will be independently tested again after the chemists turn it over to me.  Robert Kane Pappas

because they have been generous sources for my film research.   

 

Sorry for the typos. It's the NAD ratio Vis a vis NQO1 that they feel is key. 



#234 Tom Andre F. (ex shinobi)

  • Guest
  • 423 posts
  • 111
  • Location:France

Posted 23 February 2016 - 11:02 AM

 


Sorry for the typos. It's the NAD ratio Vis a vis NQO1 that they feel is key. 

 

 

You cant imagin how much you make me happy to read that ! I study beta-lapachone for a while now and im also sure its a missing link in aging. I speak directly witgh the researcher involved in that beta lapachone life extension study. Nature was also interested by this study but didnt published because their control group lived shorter, probably due to some manipulation stress.

 

NAD+ pool is important, but NAD+/NADH ratio is another very important thing in aging.

 

Im very glad to see things move on positively.
 



#235 bluemoon

  • Guest
  • 762 posts
  • 94
  • Location:south side
  • NO

Posted 23 February 2016 - 03:28 PM

"   ' Beta Lapachone is very interesting. Do you have a trusted source for beta lapachone; do you take it?' That is close to a quote. Another aging researcher

 

I know had also zeroed in on the NAD rationed beta lapachone. Bottom line here is that I think they think beta lapachone could be the missing link."

 

The missing link? Of what? To what?

 

It has been ten years and neither Sinclair nor anyone else that I know of have even shown resveratrol has anti-aging effects on people.  

 



#236 Ethic

  • Guest
  • 52 posts
  • 12
  • Location:Vienna

Posted 23 February 2016 - 05:12 PM

 


Did I read this right, it had its greatest effect when administered at the beginning of the active wake cycle. Which for the rats was at dusk. Can we pin this down to a human 24-hour circadian cycle? I assume this equates to when we wake up?

 

A couple of hours prior to your most active time, that's how i'd interpret their results, you're welcome
 



#237 to age or not to age

  • Guest
  • 151 posts
  • 93
  • Location:NY

Posted 23 February 2016 - 05:19 PM

From what I have been told it is hard to keep the NAD levels up for a prolonged period due to feedback loops. It tends to readjust due to 

an underlying change in NAMPT with age. I am not a scientist but it seems that the NAD+/NADH ratio is more important than absolute levels of NAD.

The NQ01 gene drives this ratio.  Beta Lapachone drives influences NQ01.

As to Sinclair and Guarante's research, I think that in general it works as follows - (and this is true in many research areas including stem cell research);

scientists make discoveries that are on the dart board but not exactly right.  Critics and peers write papers that poke holes in this or that advance.

The media grabs hold off the story and the breakthrough is deemed wrong.  Then years later, the research comes around again, is refined, and turns out to be true in its essence after all.  This is the same thing that is happening in stem cell work, Wagers was not quite right, Conboy is more right, Wagers 

will refine her stuff and turn out to have offered some good insight. That's how it works.  The story of the initial rebuttal tends to hang around even

after it is out of date. Resveratrol and pterostilbene will likely be found to be quite valuable, particularly in combination with and NAD enhancer. 

I believe it is important to tease out combination therapies.


  • Agree x 4

#238 Ethic

  • Guest
  • 52 posts
  • 12
  • Location:Vienna

Posted 23 February 2016 - 05:34 PM

Thank you for sharing, Robert!

 

 

 

 


Sorry for the typos. It's the NAD ratio Vis a vis NQO1 that they feel is key. 

 

 

You cant imagin how much you make me happy to read that ! I study beta-lapachone for a while now and im also sure its a missing link in aging. I speak directly witgh the researcher involved in that beta lapachone life extension study. Nature was also interested by this study but didnt published because their control group lived shorter, probably due to some manipulation stress.

 

NAD+ pool is important, but NAD+/NADH ratio is another very important thing in aging.

 

Im very glad to see things move on positively.
 

 

 

Hey Tom! I've read your blog and find it very interesting, but I couldn't find any source for the CR vs. ßL results?

 

If it's true, someone should definitely try your suggestion:

 

Calorie Restriction / ß-Lapachone / ß-Lapachone+NR



#239 to age or not to age

  • Guest
  • 151 posts
  • 93
  • Location:NY

Posted 23 February 2016 - 05:38 PM

Ethic, Tom is referring to a 2012 study on Beta Lapachone out of South Korea



#240 Tom Andre F. (ex shinobi)

  • Guest
  • 423 posts
  • 111
  • Location:France

Posted 23 February 2016 - 06:05 PM

Ethic, Tom is referring to a 2012 study on Beta Lapachone out of South Korea

 

Yes, and you can check their graph here: http://www.beta-lapa...f-healthy-life/ (first graph).

 

They noted:

 

They showed a 17% increase in mean survival period compared to the control mice (the βL group: 9.1±0.2 months vs the control group: 7.8±0.3 months, p<0.001 by the log rank test), whereas the CR group showed 10% (the CR group: 8.6±0.2 months, p<0.05), suggesting that βL was more effective than CR in increasing survival rate

 

In my knowledge, its the first time we found a molecule able to provide better result in lifespan in mamals than the CR...

 

And you can check also the mitochondria protectiv effect.. Its just impressiv and its a vivo study..

 

But again, here its a NR thread, we should open and discuss it in a more general thread since its offtopic


Edited by Tom Andre F. (ex shinobi), 23 February 2016 - 06:07 PM.

  • Agree x 1





Also tagged with one or more of these keywords: nicotinamide riboside, nicotinamide, nad boosting, charles brenner, david sinclair, leonard guarente, niagen, niacinamide, nicotinamide mononucleotide

4 user(s) are reading this topic

0 members, 4 guests, 0 anonymous users

Topic Led By